Observations placeholder

Study of possible correlation between HALLUCINATION and DIMEMORFAN PHOSPHATE

Identifier

018246

Type of Spiritual Experience

Hallucination

Number of hallucinations: 1

Background

A description of the experience

Study of possible correlation between HALLUCINATION and DIMEMORFAN PHOSPHATE

About this FactMed analysis covering adverse side effect reports of DIMEMORFAN PHOSPHATE patients who developed HALLUCINATION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking DIMEMORFAN PHOSPHATE reported HALLUCINATION to the FDA. A total of 55 DIMEMORFAN PHOSPHATE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

The source of the experience

Scientist other

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

Cough medicine

Commonsteps

References